Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yasuhisa Ono, Yusuke Taneda, Tomomi Takeshima, Kosuke Iwasaki & Atsutaka Yasui. (2020) Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database. Clinical Epidemiology 12, pages 367-375.
Read now
Read now
Articles from other publishers (16)
Rahat A Memon, Syed Shah Qasim Hamdani, Ali Usama, FNU Aisha, Hayan Kundi, Mohit Mathavan, Malaika Khalid & Areeba Khan. (2022) Comparison of the Efficacy and Safety of Apixaban and Warfarin in the Prevention of Stroke in Patients With Non-valvular Atrial Fibrillation: A Meta-Analysis. Cureus.
Crossref
Crossref
Benjamin J. R. Buckley, Deirdre A. Lane, Peter Calvert, Juqian Zhang, David Gent, C. Daniel Mullins, Paul Dorian, Shun Kohsaka, Stefan H. Hohnloser & Gregory Y. H. Lip. (2022) Effectiveness and Safety of Apixaban in over 3.9 Million People with Atrial Fibrillation: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine 11:13, pages 3788.
Crossref
Crossref
Yukihiro Koretsune, Haruhiko Hoshino, Yukako MatsuoTatsuki IbukiTakeshi Morimoto. (2022) Comparative Safety and Effectiveness of Apixaban vs. Warfarin in Oral Anticoagulant-Naïve Japanese Patients With Non-Valvular Atrial Fibrillation ― A Retrospective Chart Review Study ―. Circulation Journal 86:2, pages 213-221.
Crossref
Crossref
Mario Gaio, Carmen Ferrajolo, Alessia Zinzi, Consiglia Riccardi, Pasquale Di Filippo, Ludovica Carangelo, Gorizio Pieretti, Francesco Rossi, Giovanni Francesco Nicoletti & Annalisa Capuano. (2021) Association of Direct Oral Anticoagulants (DOACs) and Warfarin With Haemorrhagic Risk by Applying Correspondence Analysis to Data From the Italian Pharmacovigilance Database – A Case Study. Frontiers in Pharmacology 12.
Crossref
Crossref
Daniel TT Chong, Felicita Andreotti, Peter Verhamme, Jamshed J Dalal, Noppacharn Uaprasert, Chun-Chieh Wang, Young Keun On, Yi-Heng Li, Jun Jiang, Koji Hasegawa, Khalid Almuti, Rong Bai, Sidney TH Lo, Rungroj Krittayaphong, Lai Heng Lee, David KL Quek, Sofian Johar, Swee-Chong Seow, Christopher J Hammett & Jack WC Tan. (2021) Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: Consensus Recommendations by the Asian Pacific Society of Cardiology on Strategies for Thrombotic and Bleeding Risk Management. European Cardiology Review 16.
Crossref
Crossref
Zhengbiao Xue, Yue Zhou, Chaoyu Wu, Jie Lin, Xin Liu & Wengen Zhu. (2019) Non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: evidences from the real-world data. Heart Failure Reviews 25:6, pages 957-964.
Crossref
Crossref
Shun Kohsaka, Jun Katada, Kumiko Saito, Aaron Jenkins, Benjamin Li, Jack Mardekian & Yasuo Terayama. (2020) Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data. Open Heart 7:1, pages e001232.
Crossref
Crossref
Alexander Jacob Sweidan, Navneet Kaur Singh, Joseph Luke Conovaloff, Matthew Bower, Leonid I Groysman, Mohammad Shafie & Wengui Yu. (2020) Coagulopathy reversal in intracerebral haemorrhage. Stroke and Vascular Neurology 5:1, pages 29-33.
Crossref
Crossref
Hiroshi Inoue, Michiaki Umeyama, Takako Yamada, Hiroyuki Hashimoto, Akira Komoto & Masahiro Yasaka. (2020) Safety and effectiveness of reduced-dose apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A sub-analysis of the STANDARD study. Journal of Cardiology 75:2, pages 208-215.
Crossref
Crossref
Ryoko Suzuki, Jun Katada, Sreeram Ramagopalan & Laura McDonald. (2020) Potential of machine learning methods to identify patients with nonvalvular atrial fibrillation. Future Cardiology 16:1, pages 43-52.
Crossref
Crossref
Yi-Hsin Chan, Hsin-Fu Lee, Tze-Fan Chao, Chia-Tung Wu, Shang-Hung Chang, Yung-Hsin Yeh, Lai-Chu See, Chi-Tai Kuo, Pao-Hsien Chu, Chun-Li Wang & Gregory Y. H. Lip. (2019) Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis. Cardiovascular Drugs and Therapy 33:6, pages 701-710.
Crossref
Crossref
Sreeram V Ramagopalan, Antoni Sicras-Mainar, Carlos Polanco-Sanchez, Robert Carroll & Jaime F de Bobadilla. (2019) Patient characteristics and stroke and bleeding events in nonvalvular atrial fibrillation patients treated with apixaban and vitamin K antagonists: a Spanish real-world study. Journal of Comparative Effectiveness Research 8:14, pages 1201-1212.
Crossref
Crossref
Matthew A. Wanat, Xin Wang, Rutugandha Paranjpe, Hua Chen, Michael L. Johnson, Marc L. Fleming & Susan M. Abughosh. (2019) Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study. Research and Practice in Thrombosis and Haemostasis 3:4, pages 674-683.
Crossref
Crossref
Hiroshi Inoue, Michiaki Umeyama, Takako Yamada, Hiroyuki Hashimoto, Akira Komoto & Masahiro Yasaka. (2019)
Safety and effectiveness of apixaban in Japanese patients with nonvalvular atrial fibrillation in clinical practice: A regulatory postmarketing surveillance, the
STANDARD
study
. Journal of Arrhythmia 35:3, pages 506-514.
Crossref
Crossref
Matthew M. BowerAlexander J. SweidanMohammad ShafieSteven AtallahLeonid I. GroysmanWengui Yu. (2019) Contemporary Reversal of Oral Anticoagulation in Intracerebral Hemorrhage. Stroke 50:2, pages 529-536.
Crossref
Crossref
Yan-Guang Li, So-Ryoung Lee, Eue-Keun Choi & Gregory Y.H. Lip. (2018) Stroke Prevention in Atrial Fibrillation: Focus on Asian Patients. Korean Circulation Journal 48:8, pages 665.
Crossref
Crossref